AGP Executive Report
Last update: 6 hours agoMedical Access: Illinois has added sickle cell disease and ovarian syndrome with chronic pain to its medical cannabis program, bringing the list to 58 qualifying conditions. New Jersey has also enacted changes to expand patient access. CBD Research: A University of Regina study is exploring CBD as a possible concussion treatment, while Australian company Avecho is advancing its CBD sleep capsule. Sleep & Side Effects: Recent reports raise concerns that long-term cannabis use may disrupt sleep, sometimes without obvious symptoms, and that high doses can worsen anxiety. Hemp Policy: A marijuana reform group is urging Congress to preserve hemp-derived THC products as federal restrictions loom.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.